跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 59,170 条关于
“GEMINI-1”
全部
59,170
临床试验
35,339
药物
7,272
机构
1,391
资讯
15,168
9个月前
Vanda Pharmaceuticals Submits BLA for Imsidolimab to Treat Rare Generalized Pustular Psoriasis
去年
Sanofi's Tolebrutinib Shows Promise in Non-Relapsing Secondary Progressive MS
4年前
FDA Approves First Eye Drops for Presbyopia Treatment, Offering Alternative to Reading Glasses
9个月前
Zasocitinib Shows Phase 3 Superiority Over Apremilast in Dermatology Trials
2年前
Tolebrutinib Shows Promise in Slowing Disability Progression in Non-Relapsing Secondary Progressive MS
2年前
BTK Inhibitors Show Promise and Face Challenges in Multiple Sclerosis Trials
去年
FDA Approves Spevigo (spesolimab) as First Treatment for Generalized Pustular Psoriasis (GPP)
去年
Vanda Acquires Global Rights to Imsidolimab for GPP in $50 Million Deal with AnaptysBio
去年
Revelation Biosciences Receives Nasdaq Continued Listing Approval, Advances Gemini Program
去年
Revelation Biosciences' Gemini Receives FDA Nod for CKD Trial
第 1 页,共 1517 页
上一页
下一页